Help us determine the efficacy of an investigational vaccine for pregnant mothers and infants.
older adults are hospitalized annually with an RSV infection
deaths annually among adults older than 65 years
hospitalizations among children younger than 5 years old
outpatient visits among children younger than 5 years old
MedPharmics is currently performing a study on a research RSV (Respiratory Syncytial Virus) vaccine in pregnant women. In this study, participants will be randomized in the third trimester of pregnancy to receive one of 2 dose levels of investigational RSV vaccine or placebo.
You may be compensated for time and travel
Phoenix, AZ / Gulfport, MS / Albuquerque, NM / Metairie, LA
18 – 49 years of age
NUMBER OF VISITS
Have you previously had RSV or just want to learn more?
You may qualify to participate in a vaccine clinical trial.